S N Tandura,V V Zarubaev,P M Anfimov et al.
S N Tandura et al.
The problem of prophylaxis and therapy of influenza infections remains one of the priority goals for medical science and practical health care. The review includes the discussion of antiviral activity of Deitiforine, a Russian chemotherapeu...
I M Lysenko,M G Romantsov
I M Lysenko
The review deals with recurrent respiratory diseases in children. The concept of frequently ill children is characterized and the properties of the pathogens are described. The factors promoting development of recurrent respiratory diseases...
[Bacterial vaginosis and trichomononiasis. Fundamental world guidelines on management and therapy of the patients] [0.03%]
[细菌性阴道炎和毛滴虫病.患者管理和治疗的基本世界指南]
M A Gomberg
M A Gomberg
The vaginal discharge is one of the most frequent symptoms requiring medical advise. Vaginal discharges are mainly associated with three diseases: bacterial vaginosis, trichomononiasis and candidiasis. The review is concerned with up-to-dat...
[Comparative efficacy of clinical use of reamberin, remaxol and ademethionine in patients with tuberculosis of the respiratory organs and liver drug-injury] [0.03%]
关于来比林、 remedies 和腺苷甲硫氨基酸在呼吸系统和肝脏结核损害患者临床应用疗效比较研究
D S Sukhanov,M V Pavlova,P K Iablonskiĭ et al.
D S Sukhanov et al.
The efficacy ofreamberin, remaxol, S-adenosyl-L-methionine (ademethionine) and 5% glucose solution was estimated in the treatment of patients with tuberculosis of the respiratory organs and drug hepatotoxicity signs confirmed by higher acti...
Randomized Controlled Trial
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2013;58(1-2):13-8. DOI: 2013
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)] [0.03%]
[new Helicobacter pylori therapy approaches (based on the Maastricht Consensus IV, Florence, 2010) ]的新疗法治疗幽门螺杆菌感染
A G Evdokimova,L V Zhukolenko,V V Evdokimov
A G Evdokimova
European recommendations for eradication of Helicobacter pylori are presented. The increase of the resistance to clarithromycin requires the necessity of rational use of quadritherapy as the first line treatment and sequential therapy inclu...
[Comparative in vitro antibacterial activity of polyhexamethylene guanidine hydrochloride and polyhexamethylene guanidine succinate] [0.03%]
聚六亚甲基胍盐酸盐和聚六亚甲基胍琥珀酸盐体外抗菌活性比较
Kam An&#x; Kha,N É Grammatikova,I A Vasilinko et al.
Kam An&#x; Kha et al.
Eye infection is one of the temporary invalidity causes that can lead to blindness. The former antibacterial components of eye drops were polyhexamethylene guanidine hydrochloride and polyhexamethylene guanidine phosphate. Polyhexamethylene...
Comparative Study
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2013;58(1-2):3-7. DOI: 2013
[Pathogenetic correction of metabolic disturbances in chronic liver affections] [0.03%]
慢性肝病代谢紊乱的病理生理纠正疗法研究
M G Romantsov,A Iu Petrov,L N Aleksandrova et al.
M G Romantsov et al.
The available drugs for the treatment of chronic liver affections (the adequate model is chronic hepatitis C) include agents of metabolic therapy, whose efficacy is not always enough, that required the search for original mitochondrial subs...
[Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases] [0.03%]
[サイクロフェロンの副作用モニタリングおよび小児慢性特定疾患治療加算患者への有効性評価]
S A Lialikov,M G Romantsov,P G Bedin et al.
S A Lialikov et al.
Two hundred fifty patients, including 100 children with frequent and prolonged diseases at the age of 4 to 7 years, 76 children at the age of 7 to 18 years and 74 subjects at the age of 22 to 57 years were observed. The patients were treate...
[Immune disturbances in patients with postnecrotic pseudocysts of the pancreas] [0.03%]
胰腺坏死后假囊肿患者的免疫紊乱
S V Morozov,V L Poluéktov,V T Dolgikh et al.
S V Morozov et al.
The aim of the study was to investigate the role of immune disturbances in development of postnecrotic pseudocysts of the pancreas. 94 patients including 74 with postnecrotic pancreatitis and pseudocysts of the pancreas were observed. The a...
[Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide] [0.03%]
甲基氧基四氢嘧啶类砜异烟腙的抗结核性能研究
B S Kibrik,O G Chelnokova,L M Terekhina et al.
B S Kibrik et al.
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of ...
Controlled Clinical Trial
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2012;57(11-12):16-21. DOI: 2012